Something interesting has been happening in India’s unlisted-share market over the past few days.
API Holdings, the parent company of PharmEasy, and Metropolitan Stock Exchange of India (MSE) have both started attracting more attention from investors. But the reasons are quite different.
API Holdings has seen a sharp movement in its indicative unlisted share price after the company reported a much better financial performance for FY26. MSE, meanwhile, is in the news after reports that Groww and Zerodha are testing integration with the exchange.
So, is there more to these developments than just a sudden rise in interest?
Let’s look at what has happened and why these two companies are being discussed in the unlisted market.
API Holdings Unlisted Shares: A Sharp Move in Just Five Days
API Holdings has seen a fairly dramatic change in its indicative unlisted share price.
The price was around ₹5.90 on September 9, 2026, and by September 14, it had moved to approximately ₹9.00. That's a rise of nearly 52.5% in five days.
For an unlisted company, that is a sizeable move in a very short period.
But looking only at the price doesn't really explain what is happening. The more interesting part is the company's latest financial performance.
API Holdings released its FY26 financial information, and several of the numbers showed improvement.
Revenue from operations increased from ₹5,872.2 crore in FY25 to ₹6,618.5 crore in FY26. The company also saw its operating performance improve, while its consolidated loss reduced significantly.
Another positive change came from cash flow. Operating cash flow, which had been negative in FY25, turned positive in FY26.
And there was one more development worth noting: API Holdings repaid its remaining ₹1,050 crore NCD facility.
Put all of these developments together, and it becomes easier to understand why the company has come back into focus.
That doesn't mean API Holdings has suddenly become a profitable company. It is still reporting a consolidated loss. But the direction of the numbers is different from what investors saw previously, and that change matters.
So, Why Are Investors Looking at PharmEasy Unlisted Shares Again?
For many people, API Holdings is closely associated with PharmEasy.
That's understandable. PharmEasy is the company's most recognisable consumer brand. But API Holdings itself is a much larger business.
Its operations extend into areas such as pharmaceutical distribution, diagnostics and other healthcare services. The group also has businesses such as Retailio and Thyrocare within its wider ecosystem.
This is important when looking at the API Holdings unlisted share price.
The investment story isn't simply about whether more people are using PharmEasy. Investors are also looking at the wider business, its financial performance and whether the company can continue improving from here.
The FY26 numbers have given investors something new to consider: the possibility of a business moving towards a healthier financial position while continuing to operate in a large healthcare market.
What Has Changed at API Holdings?
There isn't one single number that explains the recent interest.
Instead, several things have improved at the same time.
Revenue has gone up. The company's operating performance has improved. Its consolidated loss has reduced, and operating cash flow has moved into positive territory.
The reduction in debt is another part of the picture.
For someone who has followed API Holdings over the years, these aren't small details. They suggest that the company is making progress on some of the financial challenges that have been a part of its story.
The next question, naturally, is whether this improvement can continue.
That's something the coming financial periods will have to answer.
MSE Unlisted Shares Are Getting Attention for a Different Reason
MSE's story is quite different from API Holdings.
Here, the excitement isn't primarily about financial results. It's about access and potential growth in retail participation.
According to a September 9 Moneycontrol report, Groww and Zerodha are currently testing integration with MSE.
If the integration goes ahead, MSE could potentially become an additional cash-market trading option for customers using these platforms.
The reported timeline is around 3–4 months, although that isn't a confirmed launch date. The process is still subject to testing and possible changes to the brokers' trading products.
For MSE, this could be an important development.
Why?
Because an exchange can have the infrastructure and trading capabilities, but it also needs participants. Being accessible through large retail platforms could put MSE in front of a much wider pool of individual investors.
Why Could Groww and Zerodha Make a Difference?
Think about how most retail investors trade today.
They open their brokerage app, search for a stock and place an order. The process is simple, familiar and increasingly mobile-first.
If MSE becomes available through major platforms such as Groww and Zerodha, investors could potentially have another exchange option for eligible cash-market trades without having to completely change the way they invest.
For MSE, that could translate into:
More visibility among retail investors
A potentially wider participant base
Higher trading activity
Better liquidity
Greater market reach
MSE is currently reported to have around ₹400–500 crore in daily cash-market activity, including trades facilitated by its market maker.
The potential addition of large retail platforms could therefore be significant for an exchange that is trying to strengthen its position in India's capital-market ecosystem.
But there is an important distinction here:
Groww and Zerodha integration is still being tested. It has not been confirmed as a completed rollout.
MSE Has Already Raised ₹1,240 Crore
The latest development also needs to be looked at alongside MSE's recent fundraising.
The exchange raised around ₹1,240 crore across two funding rounds in December 2024 and August 2025.
Groww and Zerodha were among the participants.
That makes the current situation particularly interesting.
These brokerages have already put money into MSE. If the reported integration eventually goes live, their connection with the exchange could potentially become even more meaningful—from being investors in MSE to potentially giving their customers access to its cash market.
Of course, the actual impact will depend on how the integration works and how many investors eventually use MSE.
For now, it's a development worth following rather than a result that has already been delivered.
MSE Is Also Preparing for F&O
There is another part of the MSE story that could become important.
The exchange is preparing for a Futures & Options (F&O) segment.
However, MSE's approach is to first build sustainable activity in its cash market before moving ahead with derivatives.
According to the reported update, the F&O launch is expected around the same broad 3–4 month period, subject to the required conditions and developments.
If everything progresses as planned, MSE could potentially see two meaningful changes around the same time:
More retail access and the expansion into F&O.
For anyone tracking MSE unlisted shares, those are developments that deserve attention.
API Holdings vs MSE: Two Very Different Stories
It's interesting to see these two names attracting attention at the same time.
But the reasons are almost completely different.
API Holdings is a healthcare and turnaround story.
The recent focus is linked to better financial numbers, lower losses, positive operating cash flow and debt reduction.
MSE is a financial-market infrastructure story.
Its recent buzz is linked to potential access through Groww and Zerodha, retail participation and its plans for an F&O segment.
So, although both belong to the unlisted market, investors are looking at them through very different lenses.
Why Can Unlisted Share Prices Move So Much?
This is something worth understanding before reading too much into a sudden price movement.
A listed stock has an exchange where buyers and sellers continuously interact during market hours. Unlisted shares work differently.
There may be fewer buyers and sellers, and the price you come across is generally an indicative or negotiated price, rather than a continuously discovered exchange price.
That means even a change in demand or available supply can have a noticeable effect.
For example, if several buyers are looking for the same company's shares but only a limited number of shares are available, sellers may quote higher prices.
The opposite can happen when demand weakens.
Company news also plays a role. Financial results, fundraising, partnerships, business expansion or possible listing plans can all change how investors view an unlisted company.
This is why the movement from ₹5.90 to ₹9 in API Holdings needs some context. The price movement itself is interesting, but understanding the reasons behind investor interest is more useful.
Should Investors Buy Because the Price Has Gone Up?
This is probably the first question that comes to mind when you see a 50%+ move.
But a rising price, by itself, isn't a reason to buy.
In the case of API Holdings, investors may want to look at whether the improvement in financial performance continues, how the company manages its cash flows and debt, and what valuation the shares are being offered at.
For MSE, the important question is whether the reported broker integrations actually happen and, if they do, whether they lead to meaningful growth in participation and liquidity.
In other words, the recent price movement is a starting point for research, not the conclusion.
What Should Investors Keep an Eye On?
The next few months could be particularly interesting.
For API Holdings, investors may want to follow:
Revenue growth
EBITDA performance
Progress towards profitability
Operating cash flow
Debt levels
PharmEasy's performance
Thyrocare and other businesses
Further corporate developments
For MSE, the focus is likely to remain on:
Groww integration
Zerodha integration
Retail participation
Cash-market volumes
Liquidity
F&O plans
Future strategic developments
The key thing is to separate what has actually happened from what is still being planned.
The reported Groww and Zerodha integration, for example, is currently a testing-stage development—not a completed launch.
What Does This Say About India's Unlisted Market?
The stories of API Holdings and MSE also show why unlisted shares continue to attract attention.
Investors aren't only interested in companies that are already trading on the stock exchanges. Some are willing to look earlier, particularly when they see improving business performance, new funding, strategic developments or the possibility of a future public-market opportunity.
But unlisted investing isn't without its challenges.
Shares can be harder to buy or sell, prices can differ between transactions, and exiting an investment may take considerably longer than it would with a listed stock.
There can also be uncertainty around valuation.
That's why due diligence matters even more in this segment.
A company can have an exciting story and still not be the right investment at every price.
Final Thoughts
The recent interest in API Holdings and MSE unlisted shares comes from two very different developments.
API Holdings has given investors a more encouraging set of financial numbers, with higher revenue, improved operating performance, positive operating cash flow and a lower debt burden. The recent move in its indicative share price shows that the market is paying attention.
MSE, meanwhile, could be approaching an interesting stage of its own. The reported testing of Groww and Zerodha integration, combined with its existing cash-market activity and plans for F&O, could potentially help the exchange reach more retail investors.
But neither story is finished yet.
For API Holdings, the big question is whether the financial improvement can continue.
For MSE, it's whether the reported plans actually translate into greater participation and sustainable trading activity.
And for investors, perhaps the simplest way to look at it is this:
A rising unlisted share price can start the conversation. The company's business and fundamentals should decide whether you keep listening.
At Dhankirti, investors can explore unlisted shares and pre-IPO opportunities with a focus on transparent pricing, competitive market rates and smooth, efficient transactions.
Disclaimer: Unlisted-share prices are indicative and may vary depending on demand, supply, availability, transaction size and buyer-seller negotiations. Unlisted investments involve market, valuation and liquidity risks. This article is intended for informational and educational purposes only and should not be considered investment advice.
Frequently Asked Questions
1. Why has API Holdings' unlisted share price increased?
The recent interest follows the company's improved FY26 financial performance. Revenue increased, operating performance improved, losses narrowed, operating cash flow turned positive and the company repaid its remaining ₹1,050 crore NCD facility.
2. What is the latest API Holdings unlisted share price?
The indicative price was around ₹9 on September 14, 2026, compared with approximately ₹5.90 on September 9. Since API Holdings shares are unlisted, prices can vary depending on the transaction and market conditions.
3. Are PharmEasy and API Holdings shares the same?
PharmEasy is the consumer-facing brand, while API Holdings is the parent company. In the unlisted market, references to PharmEasy unlisted shares generally refer to API Holdings shares.
4. Why are MSE unlisted shares in the news?
MSE has attracted attention after reports that Groww and Zerodha are testing integration with the exchange. If implemented, this could potentially give MSE access to a wider retail investor base.
5. Does MSE have a fixed share price?
No. MSE's unlisted shares do not have a continuously traded NSE/BSE market price. The price available in the unlisted market is indicative and can change based on demand, supply and transaction conditions.
6. When could Groww and Zerodha integrate MSE?
The reported timeline is around 3–4 months, but the process is still subject to testing and changes. It should therefore not be treated as a confirmed launch date.
7. What is MSE's current daily cash-market activity?
MSE is reported to have around ₹400–500 crore of daily cash-market activity, including trades facilitated by its market maker.
8. Is MSE planning an F&O segment?
Yes. MSE is preparing for an F&O segment and plans to build sustainable cash-market activity before moving ahead with derivatives.
9. Does a sharp rise in an unlisted share mean it will continue rising?
Not necessarily. Unlisted prices can move quickly because of changes in demand, supply and investor expectations. A recent rise does not guarantee future performance.
10. What should I check before buying unlisted shares?
Look beyond the current price. Consider the company's financials, valuation, debt, cash flows, business outlook, availability of shares, liquidity and possible exit options before making an investment decision.
